NCT01422759View on ClinicalTrials.gov

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
ObesityHyperandrogenemiaPolycystic Ovary Syndrome
Interventions
DRUG

Spironolactone

50-100 mg PO BID (X 12 weeks)

Trial Locations (1)

22908

RECRUITING

University of Virginia Center for Research in Reproduction, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER